Log in
Enquire now
Amphivena Therapeutics

Amphivena Therapeutics

Amphivena Therapeutics is a bi-functional antibody therapy founded in 2012.

OverviewStructured DataIssuesContributors

Contents

amphivena.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Immunotherapy
Immunotherapy
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Location
San Francisco
San Francisco
Email Address
info@amphivena.com
Phone Number
+16504993178
Investors
‌
Franklin M. Berger
Korys
Korys
Kaitai Capital
Kaitai Capital
Industrial Investors
Industrial Investors
Clough Capital Partners
Clough Capital Partners
Tekla Capital Management
Tekla Capital Management
‌
StoneFund
MPM Capital
MPM Capital
...
Founded Date
2012
Total Funding Amount (USD)
76,000,000
Latest Funding Round Date
September 2019
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
2
Country
United States
United States
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Amphivena Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.